DrugPatentWatch Database Preview
Oxycodone - Generic Drug Details
What are the generic drug sources for oxycodone and what is the scope of patent protection?
Oxycodone
is the generic ingredient in six branded drugs marketed by Collegium Pharm Inc, Ani Pharms Inc, Avanthi Inc, Genus Lifesciences, Lannett Co Inc, Mayne Pharma Inc, Novel Labs Inc, Abhai Llc, Akorn, Alkem Labs Ltd, Ascent Pharms Inc, Aurolife Pharma Llc, Eywa, Hikma, Pharm Assoc, Rhodes Pharms, Specgx Llc, Vistapharm, Wockhardt Bio Ag, Purdue Pharma Lp, Roxane, Zyla, Actavis Elizabeth, Alvogen, Amneal Pharms, Epic Pharma Llc, Nesher Pharms, Nuvo Pharm, Sun Pharm Inds Inc, Vintage Pharms, and Ohemo Life, and is included in fifty-two NDAs. There are fifty patents protecting this compound. Additional information is available in the individual branded drug profile pages.Oxycodone has twenty-four patent family members in thirteen countries.
There are nineteen drug master file entries for oxycodone. One supplier is listed for this compound. There are four tentative approvals for this compound.
Summary for oxycodone
| International Patents: | 24 |
| US Patents: | 50 |
| Tradenames: | 6 |
| Applicants: | 31 |
| NDAs: | 52 |
| Drug Master File Entries: | 19 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 20 |
| Clinical Trials: | 487 |
| Patent Applications: | 7,664 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price trends for oxycodone |
| Drug Sales Revenues: | Drug sales revenues for oxycodone |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for oxycodone |
| What excipients (inactive ingredients) are in oxycodone? | oxycodone excipients list |
| DailyMed Link: | oxycodone at DailyMed |
Recent Clinical Trials for oxycodone
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Medical College of Wisconsin | Phase 2 |
| WriteSource Medical Pty Ltd | Phase 3 |
| George Clinical Pty Ltd | Phase 3 |
Generic filers with tentative approvals for OXYCODONE
| Applicant | Application No. | Strength | Dosage Form |
| Try Before You Buy | Try Before You Buy | 80MG | TABLET, EXTENDED RELEASE; ORAL |
| Try Before You Buy | Try Before You Buy | 80MG | TABLET, EXTENDED RELEASE; ORAL |
| Try Before You Buy | Try Before You Buy | 40MG | TABLET, EXTENDED RELEASE; ORAL |
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.
Pharmacology for oxycodone
| Drug Class | Opioid Agonist |
| Mechanism of Action | Full Opioid Agonists |
Medical Subject Heading (MeSH) Categories for oxycodone
Paragraph IV (Patent) Challenges for OXYCODONE
| Tradename | Dosage | Ingredient | NDA | Submissiondate |
|---|---|---|---|---|
| XTAMPZA ER | CAPSULE, EXTENDED RELEASE;ORAL | oxycodone | 208090 | 2017-11-15 |
US Patents and Regulatory Information for oxycodone
International Patents for oxycodone
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 4694207 | Try Before You Buy |
| European Patent Office | 1594467 | Try Before You Buy |
| Hungary | E037643 | Try Before You Buy |
| Cyprus | 1119831 | Try Before You Buy |
| Canada | 2491572 | Try Before You Buy |
| Australia | 2003247876 | Try Before You Buy |
| World Intellectual Property Organization (WIPO) | 2005123039 | Try Before You Buy |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for oxycodone
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1685839 | 92292 | Luxembourg | Try Before You Buy | PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2021 - 2022
NCE-1 Patent Challenge Dates 2021 - 2022
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2021, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
